• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭与慢性阻塞性肺疾病的共病:不止是巧合。

Comorbidity of heart failure and chronic obstructive pulmonary disease: more than coincidence.

作者信息

Güder Gülmisal, Rutten Frans H

机构信息

Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany.

出版信息

Curr Heart Fail Rep. 2014 Sep;11(3):337-46. doi: 10.1007/s11897-014-0212-x.

DOI:10.1007/s11897-014-0212-x
PMID:24980212
Abstract

Heart failure and COPD are very common in the elderly. As both syndromes share common risk factors, such as tobacco smoking, and pathophysiological pathways, including systemic inflammation and activation of the neurohumoral system, they frequently coincide. Because of the similar clinical presentation, diagnoses of COPD in the presence of heart failure may be difficult. If spirometry is performed, caution should be taken in the interpretation of the data, as heart failure by itself (in the absence of true COPD) may exert restrictive as well as obstructive alterations in pulmonary function testing. Once COPD is established, concurrent heart failure may impact on the accurate management of these patients as severity grading of COPD could easily be overrated, and thus there is a risk of overuse of pulmonary medication, with the risk of causing cardiac side-effects. The present review focuses on the pathophysiological interrelation of comorbid COPD and heart failure, and provides practical help on how to deal with both diseases in daily practice.

摘要

心力衰竭和慢性阻塞性肺疾病(COPD)在老年人中非常常见。由于这两种综合征有共同的危险因素,如吸烟,以及共同的病理生理途径,包括全身炎症和神经体液系统激活,它们常常同时出现。由于临床表现相似,在存在心力衰竭的情况下诊断COPD可能会很困难。如果进行肺功能测定,在解读数据时应谨慎,因为心力衰竭本身(在没有真正的COPD时)可能在肺功能测试中导致限制性和阻塞性改变。一旦确诊COPD,并发的心力衰竭可能会影响这些患者的准确管理,因为COPD的严重程度分级可能很容易被高估,从而存在过度使用肺部药物的风险,并有可能引起心脏副作用。本综述重点关注合并COPD和心力衰竭的病理生理相互关系,并为日常实践中如何处理这两种疾病提供实际帮助。

相似文献

1
Comorbidity of heart failure and chronic obstructive pulmonary disease: more than coincidence.心力衰竭与慢性阻塞性肺疾病的共病:不止是巧合。
Curr Heart Fail Rep. 2014 Sep;11(3):337-46. doi: 10.1007/s11897-014-0212-x.
2
Chronic Obstructive Pulmonary Disease and Heart Failure: A Breathless Conspiracy.慢性阻塞性肺疾病与心力衰竭:一场惊心动魄的共谋。
Heart Fail Clin. 2020 Jan;16(1):33-44. doi: 10.1016/j.hfc.2019.08.003.
3
Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey.呼吸科和心内科门诊患者中慢性心力衰竭与慢性阻塞性肺疾病的频繁共存:来自意大利多中心调查SUSPIRIUM的证据。
Eur J Prev Cardiol. 2017 Apr;24(6):567-576. doi: 10.1177/2047487316687425. Epub 2017 Jan 9.
4
Heart failure and levels of other comorbidities in patients with chronic obstructive pulmonary disease in a Swedish population: a register-based study.瑞典人群中慢性阻塞性肺疾病患者的心力衰竭及其他合并症水平:一项基于登记册的研究。
BMC Res Notes. 2016 Apr 12;9:215. doi: 10.1186/s13104-016-2008-4.
5
[Comorbidity of chronic heart failure and chronic obstructive pulmonary disease].[慢性心力衰竭与慢性阻塞性肺疾病的共病]
Pol Merkur Lekarski. 2013 Nov;35(209):251-3.
6
Italian Survey on Prevalence and Disease Management of Chronic Heart Failure and Chronic Obstructive Pulmonary Disease comorbidity in ambulatory patients. SUSPIRIUM study rationale and design.意大利门诊患者慢性心力衰竭与慢性阻塞性肺疾病合并症的患病率及疾病管理调查。SUSPIRIUM研究原理与设计。
Monaldi Arch Chest Dis. 2014 Mar;82(1):29-34. doi: 10.4081/monaldi.2014.40.
7
Three-Year Hospitalization and Mortality in Elderly Smokers with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure.老年慢性阻塞性肺疾病或慢性心力衰竭吸烟者的 3 年住院率和死亡率。
Respiration. 2019;97(3):223-233. doi: 10.1159/000492286. Epub 2018 Sep 11.
8
Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.慢性阻塞性肺疾病和慢性心力衰竭并存患者的诊断和治疗挑战
J Am Coll Cardiol. 2007 Jan 16;49(2):171-80. doi: 10.1016/j.jacc.2006.08.046. Epub 2006 Dec 29.
9
Temporal Trends in the Incidence of Heart Failure among Patients with Chronic Obstructive Pulmonary Disease and Its Association with Mortality.慢性阻塞性肺疾病患者心力衰竭发病率的时间趋势及其与死亡率的关联
Ann Am Thorac Soc. 2020 Aug;17(8):939-948. doi: 10.1513/AnnalsATS.201911-820OC.
10
[Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease].[重度外周动脉疾病患者慢性阻塞性肺疾病的诊断患病率及困难]
Pol Merkur Lekarski. 2009 Aug;27(158):92-6.

引用本文的文献

1
Lung function impairment and risk of incident heart failure: the NHLBI Pooled Cohorts Study.肺功能损害与心力衰竭事件风险:美国国立卫生研究院(NHLBI)多队列研究。
Eur Heart J. 2022 Jun 14;43(23):2196-2208. doi: 10.1093/eurheartj/ehac205.
2
Responses to incremental exercise and the impact of the coexistence of HF and COPD on exercise capacity: a follow-up study.递增运动的反应以及 HF 和 COPD 共存对运动能力的影响:一项随访研究。
Sci Rep. 2022 Jan 31;12(1):1592. doi: 10.1038/s41598-022-05503-5.
3
Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS-HF and RALES.

本文引用的文献

1
Clinical use of aclidinium in patients with COPD.在 COPD 患者中使用阿地溴铵的临床应用。
Int J Chron Obstruct Pulmon Dis. 2014 Apr 28;9:369-79. doi: 10.2147/COPD.S40193. eCollection 2014.
2
Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis.慢性阻塞性肺疾病的长效吸入疗法(β受体激动剂、抗胆碱能药物和类固醇):一项网状荟萃分析。
Cochrane Database Syst Rev. 2014 Mar 26;2014(3):CD010844. doi: 10.1002/14651858.CD010844.pub2.
3
Comparative efficacy of aclidinium versus glycopyrronium and tiotropium, as maintenance treatment of moderate to severe COPD patients: a systematic review and network meta-analysis.
在 EMPHASIS-HF 和 RALES 研究中,观察到在射血分数降低的心力衰竭合并慢性阻塞性肺疾病患者中,盐皮质激素受体拮抗剂的作用。
Eur J Heart Fail. 2022 Mar;24(3):529-538. doi: 10.1002/ejhf.2350. Epub 2021 Oct 6.
4
Implications of Managing Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases.慢性阻塞性肺疾病在心血管疾病中的管理意义
Tuberc Respir Dis (Seoul). 2021 Jan;84(1):35-45. doi: 10.4046/trd.2020.0088. Epub 2020 Oct 13.
5
[Dyspnea : A challenging symptom in the primary care setting].[呼吸困难:基层医疗环境中具有挑战性的症状]
Internist (Berl). 2020 Jan;61(1):21-35. doi: 10.1007/s00108-019-00720-z.
6
COPD and heart failure: differential diagnosis and comorbidity.慢性阻塞性肺疾病与心力衰竭:鉴别诊断及共病
Herz. 2019 Sep;44(6):502-508. doi: 10.1007/s00059-019-4814-7.
7
Prognostic influence of prior chronic obstructive pulmonary disease in patients admitted for their first episode of acute heart failure.首次因急性心力衰竭入院的患者中既往慢性阻塞性肺疾病的预后影响。
Intern Emerg Med. 2018 Apr;13(3):351-357. doi: 10.1007/s11739-018-1820-3. Epub 2018 Mar 6.
8
Impact of airflow limitation in chronic heart failure.气流受限在慢性心力衰竭中的影响。
Neth Heart J. 2017 May;25(5):335-342. doi: 10.1007/s12471-017-0965-4.
9
Influence of heart failure on resting lung volumes in patients with COPD.心力衰竭对慢性阻塞性肺疾病患者静息肺容量的影响。
J Bras Pneumol. 2016 Jul-Aug;42(4):273-278. doi: 10.1590/S1806-37562015000000290.
10
Practical approach on frail older patients attended for acute heart failure.针对因急性心力衰竭就诊的体弱老年患者的实用方法。
Int J Cardiol. 2016 Nov 1;222:62-71. doi: 10.1016/j.ijcard.2016.07.151. Epub 2016 Jul 18.
比较阿地溴铵、格隆溴铵和噻托溴铵治疗中重度 COPD 患者的维持治疗效果:系统评价和网络荟萃分析。
Int J Chron Obstruct Pulmon Dis. 2013;8:405-23. doi: 10.2147/COPD.S48967. Epub 2013 Sep 9.
4
COPD in chronic heart failure: less common than previously thought?慢性心力衰竭合并 COPD:比以前认为的更少见?
Heart Lung. 2013 Sep-Oct;42(5):365-71. doi: 10.1016/j.hrtlng.2013.07.002.
5
Clinical relevance of diagnosing COPD by fixed ratio or lower limit of normal: a systematic review.通过固定比例或正常下限诊断慢性阻塞性肺疾病的临床相关性:一项系统评价
COPD. 2014 Feb;11(1):113-20. doi: 10.3109/15412555.2013.781996. Epub 2013 Jul 17.
6
Fixed ratio or lower limit of normal as cut-off value for FEV1/VC: an outcome study.固定比值或正常下限作为 FEV1/VC 的截定值:一项结局研究。
Respir Med. 2013 Sep;107(9):1460-2. doi: 10.1016/j.rmed.2013.06.016. Epub 2013 Jul 8.
7
Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services.心力衰竭和慢性阻塞性肺疾病:医生和卫生服务面临的挑战。
Eur Heart J. 2013 Sep;34(36):2795-803. doi: 10.1093/eurheartj/eht192. Epub 2013 Jul 5.
8
Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者吸入长效支气管扩张剂的心血管安全性。
JAMA Intern Med. 2013 Jul 8;173(13):1175-85. doi: 10.1001/jamainternmed.2013.1016.
9
Prevalence of symptomatic heart failure with reduced and with normal ejection fraction in an elderly general population-the CARLA study.老年一般人群中射血分数降低和射血分数正常的有症状心力衰竭的患病率——CARLA 研究。
PLoS One. 2013;8(3):e59225. doi: 10.1371/journal.pone.0059225. Epub 2013 Mar 15.
10
Safety and tolerability of inhalational anticholinergics in COPD.吸入性抗胆碱能药物在慢性阻塞性肺疾病中的安全性和耐受性。
Drug Healthc Patient Saf. 2013;5:49-55. doi: 10.2147/DHPS.S7771. Epub 2013 Mar 8.